---
figid: PMC7156871__CAS-111-1065-g003
figlink: pmc/articles/PMC7156871/figure/cas14317-fig-0003/
number: Figure 3
caption: MicroRNA (miR)‐302/367 family participates in networks that regulate cancer
  hallmarks. Most members of the miR‐302/367 cluster inhibit the proliferation of
  tumor cells, but some contrary conclusions have been reached. The AKT signaling
  pathway plays an important role in regulating cell stemness and proliferation. In
  addition to stemness, cytostasis, and differentiation circuits, P21 and cyclin D
  (CCND) are involved in the regulation of cancer cell proliferation. Cancer cells
  show the classic hallmarks, including activation of invasion and metastasis, evasion
  of cell death and senescence, angiogenesis, the evasion of growth suppression and
  protumorigenic inflammation, as well as additional properties, such as chemotherapy/radiochemotherapy
  resistance. Some molecules, such as metadherin‐2 (MTDH2), nuclear receptor subfamily
  2 group F member 2 (NR2F2), large tumor suppressor kinase 2 (LATS2), and Yes‐associated
  transcriptional regulator (YAP), contribute to multiple signaling interactions.
  Dual contributions are orchestrated and maintained by multiple signaling interactions,
  of which only a subset is illustrated. ATRA, All‐trans retinoic acid; BCRP, ATP
  binding cassette subfamily G member 2; CCND, cyclin D; CDK, cyclin‐dependent kinase;
  CXCR4, C‐X‐C chemokine receptor type 4; DCUN1D1, cullin neddylation 1 domain containing
  1; E2F3, E2 transcription factor 3; EGFR, epidermal growth factor recptor; ER, estrogen
  receptor; ErbB4, Receptor tyrosine‐protein kinase erbB‐4; GSK‐3β, glycogen synthase
  kinase‐3β; IGF‐1R, insulin‐like growth factor 1 receptor; IL‐8, interleukin‐8; ITGAV,
  Integrin alpha‐V; Klf2, Kruppel like factor 2; Mcl‐1, myeloid cell leukemia sequence
  1; MEKK, MAP/ERK kinase kinase 1; MICA/B, major histocompatibility complex class
  I chain‐related chain‐related proteins A and B; P‐gp, P‐glycoprotein; RAB23, Ras‐related
  protein 23; SDC1, syndecan 1; VE‐cadherin, vascular E‐cadherin; ZEB1, zinc finger
  E‐boxbinding 1
pmcid: PMC7156871
papertitle: Application of the microRNA‐302/367 cluster in cancer therapy.
reftext: Jiajia Liu, et al. Cancer Sci. 2020 Apr;111(4):1065-1075.
pmc_ranked_result_index: '105018'
pathway_score: 0.964478
filename: CAS-111-1065-g003.jpg
figtitle: MicroRNA (miR)‐302/367 family participates in networks that regulate cancer
  hallmarks
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7156871__CAS-111-1065-g003.html
  '@type': Dataset
  description: MicroRNA (miR)‐302/367 family participates in networks that regulate
    cancer hallmarks. Most members of the miR‐302/367 cluster inhibit the proliferation
    of tumor cells, but some contrary conclusions have been reached. The AKT signaling
    pathway plays an important role in regulating cell stemness and proliferation.
    In addition to stemness, cytostasis, and differentiation circuits, P21 and cyclin
    D (CCND) are involved in the regulation of cancer cell proliferation. Cancer cells
    show the classic hallmarks, including activation of invasion and metastasis, evasion
    of cell death and senescence, angiogenesis, the evasion of growth suppression
    and protumorigenic inflammation, as well as additional properties, such as chemotherapy/radiochemotherapy
    resistance. Some molecules, such as metadherin‐2 (MTDH2), nuclear receptor subfamily
    2 group F member 2 (NR2F2), large tumor suppressor kinase 2 (LATS2), and Yes‐associated
    transcriptional regulator (YAP), contribute to multiple signaling interactions.
    Dual contributions are orchestrated and maintained by multiple signaling interactions,
    of which only a subset is illustrated. ATRA, All‐trans retinoic acid; BCRP, ATP
    binding cassette subfamily G member 2; CCND, cyclin D; CDK, cyclin‐dependent kinase;
    CXCR4, C‐X‐C chemokine receptor type 4; DCUN1D1, cullin neddylation 1 domain containing
    1; E2F3, E2 transcription factor 3; EGFR, epidermal growth factor recptor; ER,
    estrogen receptor; ErbB4, Receptor tyrosine‐protein kinase erbB‐4; GSK‐3β, glycogen
    synthase kinase‐3β; IGF‐1R, insulin‐like growth factor 1 receptor; IL‐8, interleukin‐8;
    ITGAV, Integrin alpha‐V; Klf2, Kruppel like factor 2; Mcl‐1, myeloid cell leukemia
    sequence 1; MEKK, MAP/ERK kinase kinase 1; MICA/B, major histocompatibility complex
    class I chain‐related chain‐related proteins A and B; P‐gp, P‐glycoprotein; RAB23,
    Ras‐related protein 23; SDC1, syndecan 1; VE‐cadherin, vascular E‐cadherin; ZEB1,
    zinc finger E‐boxbinding 1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LATS2
  - EGFR
  - RYR3
  - RAB23
  - CXCL8
  - IGF1R
  - CXCR4
  - AKT2
  - AKT1
  - DCUN1D1
  - YY1AP1
  - CDKN1B
  - BCL2
  - SDC1
  - LRP8
  - CDK1
  - MCL1
  - ZEB1
  - BAX
  - E2F3
  - CCND2
  - CCND1
  - NR2F2
  - CDH5
  - MTDH
  - MICA
  - ABCG2
  - MICB
  - ABCB1
  - KLRK1
  - MAP3K1
  - MAPK3
  - MAPK1
  - MICA
genes:
- word: LATS2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RYR3
  symbol: RYR3
  source: hgnc_symbol
  hgnc_symbol: RYR3
  entrez: '6263'
- word: RAB23
  symbol: RAB23
  source: hgnc_symbol
  hgnc_symbol: RAB23
  entrez: '51715'
- word: IL-8
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: LATS2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: CXCR4
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
- word: АКT1/2
  symbol: AKT2
  source: hgnc_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКT1/2
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: DCUN1D1
  symbol: DCUN1D1
  source: hgnc_symbol
  hgnc_symbol: DCUN1D1
  entrez: '54165'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: P27(Kip1)
  symbol: P27KIP1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1B
  entrez: '1027'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: SDC1
  symbol: SDC1
  source: hgnc_symbol
  hgnc_symbol: SDC1
  entrez: '6382'
- word: (Mcl-1
  symbol: MCI1
  source: hgnc_alias_symbol
  hgnc_symbol: LRP8
  entrez: '7804'
- word: CDK1
  symbol: CDK1
  source: hgnc_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: Mcl-1
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: (ZEB1
  symbol: ZEB1
  source: hgnc_symbol
  hgnc_symbol: ZEB1
  entrez: '6935'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: SDC1
  symbol: SDC1
  source: hgnc_symbol
  hgnc_symbol: SDC1
  entrez: '6382'
- word: E2F3
  symbol: E2F3
  source: hgnc_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: CCND1/2
  symbol: CCND2
  source: hgnc_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CCND1/2
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: NR2F2
  symbol: NR2F2
  source: hgnc_symbol
  hgnc_symbol: NR2F2
  entrez: '7026'
- word: NR2F2
  symbol: NR2F2
  source: hgnc_symbol
  hgnc_symbol: NR2F2
  entrez: '7026'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: MTDH
  symbol: MTDH
  source: hgnc_symbol
  hgnc_symbol: MTDH
  entrez: '92140'
- word: MTDH
  symbol: MTDH
  source: hgnc_symbol
  hgnc_symbol: MTDH
  entrez: '92140'
- word: MICA
  symbol: MICA
  source: hgnc_symbol
  hgnc_symbol: MICA
  entrez: '100507436'
- word: BCRP
  symbol: BCRP
  source: hgnc_alias_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
- word: MICB
  symbol: MICB
  source: hgnc_symbol
  hgnc_symbol: MICB
  entrez: '4277'
- word: P-gp
  symbol: P-gp
  source: hgnc_alias_symbol
  hgnc_symbol: ABCB1
  entrez: '5243'
- word: NKG2D
  symbol: NKG2D
  source: hgnc_alias_symbol
  hgnc_symbol: KLRK1
  entrez: '22914'
- word: MEKK1)
  symbol: MEKK1
  source: hgnc_prev_symbol
  hgnc_symbol: MAP3K1
  entrez: '4214'
- word: Erk1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Erk1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: MICA
  source: MESH
  identifier: C099187
diseases: []
---
